drugset / Trial / NCT01466361

Evaluation of the Nicotine Lozenge in Relief of Provoked Acute Craving

NCT01466361

Phase 2 Completed 187 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is designed to evaluate the ability of a nicotine lozenge to relieve craving for a cigarette compared to a matched placebo (a placebo is like sugar pill and contains no active).

Timeline

Start
2010-09
Primary completion
2010-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nicotine Unknown 1.5 mg
Comparator Nicotine Unknown 4 mg

Indications

No indication recorded.